Table 2.

Changes in HbA1c in the Ly study (Mean [95% Confidence Interval]; n/N).

	Start of the study	End of the study (6 months)	Change in HbA1c	Group differenceaP value
LGS	7.6 [7.4, 7.9]; 46/46	7.5 [7.3, 7.7]; 46/46	–0.1 [–0.3, 0.03]	0.07 [–0.2; 0.3]; P = 0.55
SMBG	7.4 [7.2, 7.6]; 49/49	7.4 [7.2, 7.7]; 49/49	–0.06 [–0.2, 0.09]

^aResult from mixed-effects model repeated measures, adjusted according to HbA1c value at the start of the study, visit interaction, age group interaction, as well as age group × visit interaction, age group × treatment group interaction, and treatment group × visit interaction. n, number of patients analyzed; N, number of randomized patients.